|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
on1056073109 |
| 003 |
OCoLC |
| 005 |
20240809213013.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
181006s2018 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d TUHNV
|d SGP
|d OCLCQ
|d OCLCL
|
| 066 |
|
|
|c (S
|
| 020 |
|
|
|a 9781615372034
|
| 020 |
|
|
|a 1615372032
|
| 035 |
|
|
|a (OCoLC)1056073109
|
| 050 |
|
4 |
|a RM315
|b .G653 2019eb
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Goldberg, Joseph F.
|
| 245 |
1 |
0 |
|a Managing the Side Effects of Psychotropic Medications.
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Washington, D.C. :
|b American Psychiatric Publishing,
|c 2018.
|
| 300 |
|
|
|a 1 online resource (618 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|6 880-01
|a Cover; Half Title; Title Page; Copyright; Dedication; Contents; Foreword to the Second Edition; Preface; List of Abbreviations; List of Drugs; PART I General Considerations; 1 The Psychiatrist as Physician; Primary Care Psychiatry; Differentiating Adverse Drug Effects From Primary Illness Symptoms or Nonpsychiatric Medical Problems; The Nocebo Phenomenon and Proneness to Adverse Effects; Negative Therapeutic Reactions; Attribution and Causality; Paradoxical Adverse Effects; Extrapolating "Evidence-Based Research Findings" to "Real-World" Patients; Dose Relationships and Adverse Effects.
|
| 505 |
8 |
|
|a FDA Warnings and PrecautionsRisk-Benefit Analyses; General Approach to Assessing Adverse Drug Effects; 2 Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics; Pharmacokinetics and Pharmacodynamics; Toxic Polypharmacy; Gender and Racial Differences in Adverse Effects; Alcohol; Brand Versus Generic Formulations; Enantiomeric Versus Racemic Agents, and Parent Versus Metabolite Compounds; Drug Blood Levels; Pharmacogenomic Predictors of Adverse Effects; 3 Vulnerable Populations; Patients' Diverse Proneness to Drug Side Effects; Children; Medically Ill Patients; Older Adults.
|
| 505 |
8 |
|
|a Clinical Trial Subjects With Psychiatric IllnessDiscontinuation Phenomena; Disinhibition and Impaired Impulse Control; Emotional Dulling; Psychosis; Suicidal Thinking or Behavior; 6 What Nonmedical Therapists Should Know About Adverse Drug Effects; PART II Organ Systems; 7 Cardiovascular System; Arrhythmias and Palpitations; Cerebrovascular Accidents; Edema; Hypertension; Myocarditis and Cardiomyopathy; Orthostatic Hypotension; 8 Dermatological System; Alopecia; Hyperhidrosis; Photosensitivity; Pruritus; Skin Rashes; 9 Ear, Nose, and Throat; Bruxism; Dysarthria; Dysgeusia; Oral Lesions.
|
| 505 |
8 |
|
|a SialorrheaStomatodynia (Burning Mouth Syndrome); Tinnitus; Xerostomia; 10 Electrolyte Abnormalities; Hyponatremia and SIADH; Metabolic Acidosis and Alkalosis; 11 Endocrinopathies; Bone Demineralization and Osteoporosis; Hyperprolactinemia, Galactorrhea, and Gynecomastia; Menstrual Disturbances and Polycystic Ovary Syndrome; Parathyroid Abnormalities; Thyroid Abnormalities; 12 Gastrointestinal System; Diarrhea, Hypermotility, and Constipation; Gastrointestinal Bleeding; Hepatic Impairment and Transaminitis; Hyperammonemia; Malabsorption Disorders; Nausea and Gastrointestinal Upset.
|
| 500 |
|
|
|a Pancreatitis.
|
| 520 |
|
|
|a This second edition of the guide features updated information about newer psychotropic agents, as well as new drugs to help manage iatrogenic weight gain, metabolic dysregulation, involuntary movement disorders, and other common problems.
|
| 700 |
1 |
|
|a Ernst, Carrie L.
|
| 700 |
1 |
|
|a Stahl, Stephen M.
|
| 758 |
|
|
|i has work:
|a Managing the side effects of psychotropic medications (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGf4vvRhBvBW6qdXy6g8yd
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Goldberg, Joseph F.
|t Managing the Side Effects of Psychotropic Medications.
|d Washington, D.C. : American Psychiatric Publishing, ©2018
|z 9781585624881
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=5524373
|y Click for online access
|
| 880 |
8 |
|
|6 505-01/(S
|a Patients Prone to Somatization4 Adverse Psychiatric Effects of Nonpsychotropic Medications; Analgesics; Anticholinergics; Anticonvulsants; Antimicrobials; Antineoplastics; Antiparkinsonian Agents; Antiviral and Antiretroviral Agents; Cardiovascular Drugs; Dermatological Agents; Gastrointestinal Agents; Hormone Supplements; Immunosuppressants; Interferon-α; Oral Contraceptives and Intravaginal Rings; Smoking Cessation Aids; Steroids; 5 Adverse Psychiatric Effects of Psychiatric Medications; Activation and Mania/Hypomania or Mixed States; Anxiety and Panic.
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|